5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Shalby Ltd.

•
shalby.orgBSE: 540797NSE: SHALBY
Market Cap₹ 1,608 Cr.
Current Price
High / Low₹ 275 / 126
Stock P/E14.3
Book Value₹ 118
Price to Book1.09
Dividend Yield0.00 %
ROCE10.0 %
ROE9.5 %
Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company has delivered good profit growth of 21.4% CAGR over last 5 years
  • Company is almost debt free
  • Company has delivered good sales growth of 16.5% CAGR over last 5 years
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.26x)
  • Stock looks reasonably valued - P/E of 14.3 is below its historical median
  • Company comfortably covers its interest (9.0x coverage)

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • Company has a low return on equity of 9.1% over last 3 years
  • Operating margins have contracted to 16.3% from 23.0%
  • Though reporting repeated profits, the company pays out little dividend (0.0%)
  • Growth is decelerating - 3Y profit CAGR (11.8%) trails the 5Y trend (21.4%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcareHospital & Healthcare Services
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.APOLLOHOSP8960.0061.66128831.050.22610.4038.417043.5020.5621.7315.70
2.MAXHEALTH1036.5069.24100883.610.19322.964.872366.1716.7014.9725.29
3.MANIPALHOS729.95107.6096015.960.002434.30—30906.30—13.9323.83
4.FORTIS911.9065.7068844.630.11272.802.262545.0317.4614.0721.28
5.ASTERDM780.05213.3667994.810.0029.28-68.701310.6821.6011.4619.53
6.MEDANTA1479.7571.5439786.300.03157.25-1.091304.0526.5019.3821.99
7.NH1888.8047.3038599.670.24207.275.372683.6378.0516.2017.43
8.LALPATHLAB1919.4559.4532217.741.071705.001172.397977.001090.9529.5631.03
9.KIMS764.80157.2332122.100.0037.40-56.001179.5035.3311.5119.03
10.AGARWALEYE514.20109.8716301.490.0055.0244.56614.0225.9716.1427.75
11.VIJAYA1496.8582.2315417.210.1353.1037.61230.9822.8330.2842.66
12.SHALBY148.9040.911608.270.0010.5036.70331.2211.746.8812.56
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
211217195206233212221207237224215225254
167165152168182177178176190185186193225
Operating Profit45524338503543314739303129
OPM %21.11%23.83%22.14%18.54%21.63%16.69%19.28%14.86%19.79%17.40%13.77%13.99%11.27%
5654856766655
Interest1111333334423
Depreciation9999101010101010101111
Profit before Tax40473833462836264031222334
Tax %34.56%35.79%35.76%30.63%33.53%38.72%41.68%41.74%35.94%35.37%36.95%-128.77%26.03%
Net Profit26302523301721152620145425
2.442.832.302.102.841.601.941.392.391.841.284.992.33

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
322380462484419647708830869899918
250300379401332516565651712752789
Operating Profit7380848387131143179157146129
OPM %22.53%21.01%18.06%17.06%20.79%20.29%20.24%21.57%18.07%16.30%14.02%
6109181092021302422
Interest1112974444131413
Depreciation1622333637363737394041
Profit before Tax5255515755100121158136116110
Tax %41.63%26.36%36.72%50.95%22.73%30.14%33.41%34.40%38.27%2.66%-2.28%
Net Profit3040322843708110484113112
EPS0.000.000.000.003.976.467.489.677.8010.50—
Dividend Payout %0.00%0.00%16.82%19.31%25.19%15.47%15.94%12.41%0.00%0.00%—

COMPOUNDED SALES GROWTH

10 Years:
12%
5 Years:
17%
3 Years:
8%

COMPOUNDED PROFIT GROWTH

10 Years:
11%
5 Years:
21%
3 Years:
12%

STOCK PRICE CAGR

10 Years:
—
5 Years:
-5%
3 Years:
-17%
1 Year:
-38%

RETURN ON EQUITY

10 Years:
8%
5 Years:
9%
3 Years:
9%
Last Year:
9%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2024

Sep 19

₹ 0.12

Rs.1.2000 per share(12%)Final Dividend

2023

Aug 8

₹ 0.12

Rs.1.2000 per share(12%)Final Dividend

2022

Sep 19

₹ 0.10

Rs.1.0000 per share(10%)Final Dividend

2021

Sep 17

₹ 0.10

Rs.1.0000 per share(10%)Final Dividend

2020

Sep 4

₹ 0.05

Rs.0.5000 per share(5%)Final Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital87108108108108108107107107108
1716576867067427998629541,0251,138
336127837864614311899115
Trade Payables394959605961737379103
1111027989109147190232194191
Total Liabilities7441,0431,0151,0421,0821,1761,2751,4851,5051,655
312647689670658628603599579621
Capital Work in Progress2214623446580
101024433262313511599623
8121315202018172025
0000000118132180
Cash & Bank16115252983104392213
178212262283285357332224145193
Total Assets7441,0431,0151,0421,0821,1761,2751,4851,5051,655

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
822756778612419214014991
Cash from Investing-157-242-0-32-52-40-172-206-101-109
Cash from Financing89226-51-21-28-17-3872-369
3-1-63-243-46612-8

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
74.2574.2574.2774.2774.2774.3374.3374.3374.33
5.355.374.654.545.214.634.474.364.47
0.060.090.140.180.190.190.190.250.30
Government0.000.000.000.000.000.000.000.000.00
Public20.3520.2920.9421.0220.3320.8421.0121.0720.91

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-10
Shareholders meeting

2026-09-10 - Outcome and Proceeding of 22nd Annual General Meeting held on 10th September 2026

2026-08-20
Updates

2026-08-20 - Shalby Limited has informed the Exchange regarding 'Weblink letter to Shareholders whose email IDs are not registered intimating exact path of Annual Report FY 2025-26 and Notice of 22nd AGM'.

2026-08-19
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-19 - Shalby Limited has informed the Exchange about Transcript

2026-08-19
Copy of Newspaper Publication

2026-08-19 - Shalby Limited has informed the Exchange about Copy of Newspaper Publication - Notice of AGM and E-voting information post despatch of the same

2026-08-18
Resignation of Director/KMP/SMP

2026-08-18 - Shalby Limited has informed the Exchange about Resignation of Director/KMP/SMP

2026-08-18
Resignation

2026-08-18 - Shalby Limited has informed the Exchange regarding Resignation of Mr Deepak Anand as Chief Executive Officer of Shalby Medtech Limited (a wholly-owned subsidiary) w.e.f. September 04, 2026.

2026-08-14
Copy of Newspaper Publication

2026-08-14 - Shalby Limited has informed the Exchange about Copy of Newspaper Publication relating to Pre-despatch Notice of AGM

2026-08-13
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-13 - Shalby Limited has informed the Exchange about Link of Recording

2026-08-13
Copy of Newspaper Publication

2026-08-13 - Shalby Limited has informed the Exchange about Copy of Newspaper advertisement relating to unaudited financial results for quarter ended June 30, 2026

News

Recent coverage and analyst commentary for SHALBY

Loading news…

🤖

AI Stock Analyst

Shalby Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login